- Home
- KALA vs EBON Comparison
KALA vs EBON Comparison
Compare KALA & EBON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- EBON
- Stock Information
- Founded
- KALA 2009
- EBON 2010
- Country
- KALA United States
- EBON China
- Employees
- KALA N/A
- EBON N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- EBON Semiconductors
- Sector
- KALA Health Care
- EBON Technology
- Exchange
- KALA Nasdaq
- EBON Nasdaq
- Market Cap
- KALA 26.2M
- EBON 25.3M
- IPO Year
- KALA 2017
- EBON 2020
- Fundamental
- Price
- KALA $8.58
- EBON $4.05
- Analyst Decision
- KALA Strong Buy
- EBON
- Analyst Count
- KALA 3
- EBON 0
- Target Price
- KALA $14.00
- EBON N/A
- AVG Volume (30 Days)
- KALA 183.0K
- EBON 11.3K
- Earning Date
- KALA 08-08-2025
- EBON 08-15-2025
- Dividend Yield
- KALA N/A
- EBON N/A
- EPS Growth
- KALA N/A
- EBON N/A
- EPS
- KALA N/A
- EBON N/A
- Revenue
- KALA N/A
- EBON $7,337,066.00
- Revenue This Year
- KALA N/A
- EBON N/A
- Revenue Next Year
- KALA N/A
- EBON N/A
- P/E Ratio
- KALA N/A
- EBON N/A
- Revenue Growth
- KALA N/A
- EBON 104.28
- 52 Week Low
- KALA $2.92
- EBON $3.00
- 52 Week High
- KALA $11.20
- EBON $10.94
- Technical
- Relative Strength Index (RSI)
- KALA 67.01
- EBON 46.95
- Support Level
- KALA $7.38
- EBON $3.89
- Resistance Level
- KALA $7.71
- EBON $4.19
- Average True Range (ATR)
- KALA 0.79
- EBON 0.26
- MACD
- KALA 0.03
- EBON -0.04
- Stochastic Oscillator
- KALA 92.58
- EBON 37.88
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.